Evidence map›Paper›PMID 27891296›Full record

ArticleJournal of cachexia, sarcopenia and muscle2016

Welcome to the ICD-10 code for sarcopenia.

Stefan D Anker, John E Morley, Stephan von Haehling

Open access · goldAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cachexia, sarcopenia and muscle, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 508 papers, 12 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
508citing papers in PubMed, 12 pooled it
29.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

508 citing papers in PubMed, 12 syntheses or guidelines pooled it, 1,120 citations in OpenAlex.

  1. How Pragmatic Are Sarcopenia Intervention Studies? A Systematic Review.Journal of cachexia, sarcopenia and muscle · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Pooled it
  13. Trial
  14. Trial
  15. Article
  16. [Sarcopenia: diagnosis, clinical implications, and treatment].Innere Medizin (Heidelberg, Germany) · 2026
    Review
  17. Review
  18. Review
  19. Article
  20. Article

448 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Stefan D AnkerInnovative Clinical Trials, Department of Cardiology and Pneumology University of Göttingen Medical Centre, Georg-August-University Göttingen Germany.
John E MorleyDivisions of Geriatric Medicine and Endocrinology Saint Louis University School of Medicine St. Louis MO USA.
Stephan von HaehlingInnovative Clinical Trials, Department of Cardiology and Pneumology University of Göttingen Medical Centre, Georg-August-University Göttingen Germany.
University of Göttingen · DESaint Louis University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new ICD-10-CM (M62.84) code for sarcopenia represents a major step forward in recognizing sarcopenia as a disease. This should lead to an increase in availability of diagnostic tools and the enthusiasm for pharmacological companies to develop drugs for sarcopenia.

Indexed as

International Classification of DiseasesHumansSarcopeniaAgingICD codeSarcopenia

Identifiers

PMID27891296
PMCPMC5114626
OpenAlexW2536212044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.